自发性高血压大鼠颈总动脉的平均壁面切应力和周向应力

目的确定自发性高血压大鼠(SHR)颈总动脉的平均壁面切应力(WSS)和周向应力(CS),并与同龄正常血压大鼠(WKY)相对比,观察SHR和WKY大鼠颈总动脉平均WSS和CS的特征。方法选取12周龄SHR作为动物模型,同龄WKY为对照组;通过在体测定颈总动脉的平均血流量与平均血压,离体测量颈总动脉的无载荷状态形态学数据,以及在体轴向伸长比条件下颈总动脉段的压力(p)-容积(V)关系,确定颈总动脉平均WSS和CS;同时比较SHR和WKY颈总动脉的平均血压和血流量、无载荷和载荷状态几何尺寸以及平均WSS和CS的特征。结果与正常血压的WKY组相比,SHR组颈总动脉血压明显增高、流量明显降低;无载荷和载荷状态下SHR组动脉的内外半径均增大,载荷状态下SHR组动脉壁厚减小;SHR颈总动脉平均WSS明显降低,而CS明显增高。结论高血压和低流量引起了SHR颈总动脉重建;低WSS和高CS是SHR颈总动脉血液动力学参数的重要特征;WSS和CS的协同作用可能是反映动脉重建的敏感指标之一。     

川芎嗪和丹参对正常及高血压大鼠血25(OH)D、Ca、P及ALP水平的影响

已有资料表明:低钙摄取会增加WKY大鼠的血压,而高钙摄取则可降低WKY大鼠和SHR的血压;临床资料证实:高血压病人钙摄取低于正常人;而流行病学调查指出高血压与低钙有关。因此高血压伴有钙、磷代谢异常是一个值得注意的课题,本文目的在于考察高血压大鼠血中某些钙、磷代谢相关指标,同时观察活血化瘀药川芎嗪和丹参对它们的影响。     

抗血管紧张素Ⅱ1型受体抗体对自发性高血压大鼠血压和肾脏的影响

目的观察血管紧张素Ⅱ1型受体(AT1受体)胞外不同肽段主动免疫对自发性高血压大鼠(SHR)血压和肾脏的影响。方法人工合成的AT1受体胞外肽段主动免疫SHR。动态监测SHR血压变化,观察肾脏组织病理变化,RT-PCR法检测肾脏组织原癌基因表达水平。结果ATR12181组血压为(179.0±13.6)mmHg较对照组(188.0±9.9)mmHg下降(P<0.05)。ATR12181组相比对照组肾脏病理变化减轻,ATR11188组相比对照组病变加重。ATR12181组cf-os、cj-un表达水平明显低于对照组(P<0.05),ATR11188组则明显高于对照组(P<0.05)。结论不同肽段免疫产生的不同抗体对SHR血压和肾脏可产生不同的影响。     

加压素在自发性高血压大鼠与正常大鼠下丘脑视上核、室旁核神经元内表达

目的观察加压素(AVP)在自发性高血压大鼠(SHR)与正常大鼠下丘脑视上核(SON)、室旁核(PVN)内的分布。方法应用光镜和免疫细胞化学技术。结果SHR的AVP阳性细胞内分泌颗粒密集呈棕黄色,正常大鼠组则染色较浅。SHR大鼠SON内AVP阳性神经元百分数(69.30±18.10%)明显多于正常大鼠(59.53±16.97%,P<0.05),而两组大鼠PVN内AVP的表达无明显差异。结论AVP在下丘脑的血压调节活动中起着重要的介导作用,中枢AVP含量的异常增加可能与高血压的发病有关。     

螺内酯和缬沙坦对高血压大鼠肠系膜微动脉重塑的影响

目的:观察盐皮质激素受体拮抗剂螺内酯和血管紧张素Ⅱ(AngⅡ)AT1受体拮抗剂缬沙坦对自发性高血压大鼠(SHR)肠系膜微动脉形态、超微结构和Ⅰ型胶原mRNA表达的影响。方法:将18只雄性SHR随机分为三组,每组6只,其中两组分别用螺内酯20mg/kg/天、缬沙坦30mg/kg/天溶于饮水中灌胃,连续治疗13周,对照组不用药,正常饮水,并与WKY大鼠(6只)比较。鼠尾法测量大鼠动脉收缩压;应用计算机图像分析系统,计算大鼠肠系膜微动脉管壁与管腔横截面积比;用透射电镜观察大鼠肠系膜微动脉结构的变化;用RT-PCR方法检测肠系膜微动脉Ⅰ型胶原mRNA水平。结果:实验第13周末,SHR对照组血压明显高于WKY组(P<0.01);缬沙坦组和螺内酯组血压明显低于SHR对照组(P<0.01);缬沙坦组的血压与WKY组接近(P>0.05)。螺内酯组和缬沙坦组大鼠肠系膜微动脉的中膜厚度/管腔半径值及中膜面积/管腔面积值仍显著大于WKY组(P<0.05),但较SHR组明显降低(P<0.01)。透射电镜见SHR肠系膜动脉壁有大片纤维组织增生,螺内酯组和缬沙坦组肠系膜动脉壁内仅见少许纤维组织增生。螺内酯组和缬沙坦组Ⅰ型胶原mRNA水平明显低于SHR对照组(P<0.01)。结论:螺内酯和缬沙坦均能抑制SHR的Ⅰ型胶原合成,表明盐皮质激素受体和AngⅡ受体在高血压阻力血管的重塑中起着重要作用。     

自发性高血压大鼠中脑导水管周围灰质nNOS阳性神经元的变化

目的观察自发性高血压大鼠(spontaneously hypertensiverats,SHR)中脑导水管周围灰质内神经元型一氧化氮合酶(neuronal nitric oxide synthase,nNOS)阳性神经元的变化。方法取SHR和京都种威斯特大鼠(Wistar-Koytorats,WKY)大鼠各30只,分别于3月(14周)龄,6月龄和12月龄测血压并处死,ABC免疫细胞化学方法显示nNOS阳性神经元。结果SHR血压随鼠龄的增长逐渐升高,于12～14周龄时血压在高位稳定,且均高于WKY大鼠(P<0.05)维持在[(20.8±1.1)～(26.3±1.0)]kPa(P<0.05);WKY大鼠各时期血压无明显差异,维持在[(13.7±1.6)～(15.1±1.7)]kPa。中脑导水管周围灰质nNOS阳性神经元以小细胞为主,突起有2-4个,许多朝中脑水管方向延伸。定量结果显示,SHR大鼠nNOS阳性神经元随着血压升高呈逐渐减少的趋势,12月龄与3月龄和6月龄相比均有显著差异(P<0.01),而各个时期WKY大鼠PAGnNOS阳性神经元均无明显变化。结论SHR中脑导水管周围灰质nNOS阳性神经元的减少可能通过影响延髓的血压调节中枢调控高血压的发生,并有可能与高血压的痛觉过敏有关。     

不同周龄自发性高血压大鼠动态血压变化及阻力血管形态学研究

目的: 观察不同周龄自发性高血压大鼠(SHR)动态血压变化及阻力血管形态。方法: 分别选用16周及40周龄的SHR模型,使用遥感监测技术观察清醒、无拘束SHR的动态血压变化,分析不同周龄SHR的血压昼夜变化及变异度,比较不同周龄SHR阻力血管的形态学变化。结果: 40周SHR较16周SHR 24 h血压均值高,但无显著差异;16周SHR夜间血压下降率较40周明显升高(P<0.05);40周SHR 血压变异系数较16周SHR明显增大。肠系膜动脉(阻力血管)中膜面积/管腔面积比值随着周龄的增加而增加,5周、16周与40周相比有显著差异(P<0.05)。结论: 40周SHR动态观察24 h血压变异度较16周SHR大,且随着周龄的增加,阻力血管(肠系膜动脉)的中膜面积/管腔面积增加。     

L-苯丙氨酸对自发性高血压大鼠血液NO、ET和SOD水平的影响

目的： 探讨苯丙氨酸对自发性高血压大鼠(SHR)血浆NO、ET和SOD水平的影响。方法: 以11只4周龄雄性SHR 为实验对象,分为苯丙氨酸饲喂组（n=6）及对照组（n=5）;另以相同周龄的WKY大鼠（n=6）作为正常对照组。至实验大鼠30和42周龄时，检测血浆NO、ET和SOD的水平。结果: SHR血浆NO水平明显高于WKY (P<0.01)，血浆ET水平明显低于WKY (P<0.01)；苯丙氨酸治疗后抑制SHR血压的上升，血浆SOD及ET水平明显上升(P<0.01)；血浆NO水平明显下降(P<0.01)。结论: 苯丙氨酸可调节氧自由基的清除和改善内皮细胞的内分泌功能，这可能是苯丙氨酸新的降低血压的机制。     

苯那普利对高血压大鼠细胞外信号调节激酶和B型钠尿肽的影响

目的：研究苯那普利对自发性高血压大鼠（SHR）细胞外信号调节激酶（ERK）和B型钠尿肽（BNP）的影响。方法：选择Wistar Kyoto（WKY）大鼠作对照，将21只14周龄雄性SHR随机分成3组：未治疗组、肼苯哒嗪组和苯那普利组，每组7只。药物溶于载体（0.5%羧甲基纤维素钠）以灌胃法给予，肼苯哒嗪10 mg·kg-1·d-1，苯那普利10 mg·kg-1·d-1，SHR未治疗组及WKY组灌喂载体，共10周。以左心室重量与体重的比值反映心肌肥厚的程度；用袖带式尾动脉测压法测量大鼠尾动脉血压；分别用Western blotting方法和RT-PCR法半定量测定大鼠心肌中磷酸化ERK（p-ERK）的蛋白表达以及BNP mRNA的含量；酶联免疫吸附法检测大鼠血浆BNP水平。结果：（1） 治疗后SHR苯那普利组和SHR肼苯哒嗪组血压相似，均显著低于SHR未治疗组（P<0.01）。（2） SHR苯那普利组心肌肥厚指数显著低于SHR肼苯哒嗪组和SHR未治疗组(P<0.01) ，与WKY组无显著差异(P>0.05)；SHR肼苯哒嗪组和SHR未治疗组心肌肥厚指数无显著差异(P>0.05)。（3）SHR苯那普利组大鼠心肌p-ERK表达显著低于SHR肼苯哒嗪组和SHR未治疗组(P<0.05) ，与WKY组无显著差异(P>0.05)。SHR肼苯哒嗪组和SHR未治疗组大鼠心肌p-ERK表达无明显差异(P>0.05)。（4） SHR苯那普利组大鼠心肌BNP mRNA和血浆BNP水平显著低于SHR肼苯哒嗪组和SHR未治疗组(P<0.05)，与WKY组无显著差异(P>0.05)；SHR肼苯哒嗪组和SHR未治疗组大鼠心肌BNP mRNA和血浆BNP水平无明显差异(P>0.05)。结论：苯那普利能通过抑制ERK活性逆转心肌肥厚，伴随BNP水平下降；而降压效果相似的肼苯哒嗪不能抑制心肌肥厚，对p-ERK和BNP水平没有影响，提示BNP水平可以反映逆转心肌肥厚药物疗效。     

阿托伐他汀对自发性高血压大鼠细胞色素P450羟化酶基因表达的影响

目的： 评价阿托伐他汀对自发性高血压大鼠（SHR）血压和细胞色素P450羟化酶(CYP)4A1的调节作用。方法： 18只SHR随机分为3组：SHR对照组、阿托伐他汀50 mg组(HATV组)和10 mg组(LATV组)；6只Wistar-Kyoto大鼠(WKY)作为正常对照组。给药共10周,分别于给药前和给药后每2周测量大鼠尾动脉收缩压(SBP)；RT-PCR、Western blotting法检测心、肝、肾及主动脉中CYP4A1 mRNA和蛋白质表达；并测定血脂含量。结果： 用药前SHR各组SBP均显著高于WKY组(P<0.01)；HATV组在给药后第6、8、10周和LATV组在给药后第10周SBP明显低于SHR对照组(P<0.05或P<0.01)。在CYP4A1 mRNA及其蛋白质表达中，SHR对照组4种组织均明显高于WKY组(P<0.01或P<0.05)；给药10周后，HATV组心、肾及主动脉和LATV组肾和主动脉的表达均明显低于SHR对照组(P<0.01或P<0.05)；同时，用药2组血脂水平亦明显低于SHR对照组(P<0.01或 P<0.05)。结论： 阿托伐他汀可下调CYP4A1基因的表达，这可能是其降低血压的作用机制之一。     

Regulation of intestinal calcium-binding protein calcium intake in the rat.

Analytical gel electrophoresis of the vitamin D-dependent intestinal calcium-binding protein (CaBP) has demonstrated two protein bands (1 and 2) of similar molecular weight and similar specific binding activity. The mucosal concentration of CaBP, measured by a quantitative competitive binding assay, has been shown to vary reproducibly and inversely with calcium intake and the mucosal calcium concentration. These same factors also influence the relationship of bands 1 and 2. When animals on a high-calcium diet were placed on a low-calcium diet, their CaBP increased by 35% in 24 h and by 48% in 48 h and reached a level typical of animals on a low-calcium diet. Measurement of the diurnal variation of CaBP and mucosal calcium in animals allowed access to feed only at night revealed significant, but inverse, oscillations. These observations are interpreted as reflecting a regulation of CaBP by the mucosal calcium concentration, which appears to reflect absorbed calcium in transit.     

Effects of ambient and dietary cadmium on haematological parametres in Oreochromis mossambicus acclimatised to low- and high-calcium water

The haematological response to ambient (10μg Cd l⁻¹) or dietary (10μg Cd fish⁻¹ day⁻¹) cadmium for 2 and 14days was investigated in tilapia (Oreochromis mossambicus) acclimatised to low-calcium (0.2mM Ca²⁺) and high-calcium water (0.8mMCa²⁺). Significant reduction of erythrocytes (red blood cells), haemoglobin (Hb), packed cell volume (PCV), mean cell haemoglobin (MCH) and mean cell volume (MCV) occurred in fish exposed to ambient cadmium in low-calcium water. The anaemic response of significantly reduced Hb, PCV, MCH and MCV was also evident in fish exposed to dietary cadmium in low-calcium water. Except for increased mean cell volume of erythrocytes, both ambient and dietary cadmium had no effect on haematological indices in fish from high-calcium water. This study indicates that high-calcium water has a protective effect on cadmium toxicity.     

阿托伐他汀影响自发性高血压大鼠血压的机制探讨

目的：探讨阿托伐他汀控制自发性高血压大鼠（SHR）高血压的机制，研究阿托伐他汀对SHR血浆内皮素-1（ET-1）和主动脉一氧化氮合酶（NOS）的影响，以及对SHR的主动脉平滑肌细胞（ASMC）凋亡和P27蛋白表达的影响。 方法： 选用8周龄SHR 12只，随机分为阿托伐他汀治疗组（ATV组, n=6）和SHR组（n=6），并以同周龄WKY（n=6）作为对照。ATV组给以阿托伐他汀（50 mg·kg-1·d-1）灌胃。10周后观察3组大鼠血压、血清总胆固醇（TC）、总甘油三酯（TG）含量变化，血浆ET-1和主动脉NOS活性的改变，以及TUNEL法检测ASMC凋亡率，测定动脉ASMC P27蛋白表达。 结果： 阿托伐他汀给药10周后，ATV组动脉收缩压显著低于SHR组［（134.17±3.60）mmHg vs （173.33±3.78）mmHg, P<0.01］；ATV组血清TC和TG浓度均显著低于SHR组（P<0.01, P<0.01）。同时，阿托伐他汀显著降低SHR血浆ET-1水平［（130.04±40.07）ng/L vs （196.74±59.69）ng/L，P<0.05］和增加SHR主动脉NOS活性［(0.189±0.040）kU/g protein vs （0.124±0.057）kU/g protein，P<0.01］；ATV组ASMC凋亡率显著高于SHR组（16.94%±3.08% vs 9.01%±2.36%, P<0.01）；ATV组ASMC P27蛋白表达阳性率显著高于WKY大鼠（33.02%±5.01% vs 24.25%±4.41%, P<0.05），而SHR组该指标明显低于WKY大鼠（16.08%±7.09% vs 24.25%±4.41%, P<0.05）。 结论： 阿托伐他汀控制SHR血压增高，其机制可能与降低SHR的血浆ET-1水平和增高主动脉NOS活性，以及增高ASMC凋亡率和P27蛋白表达阳性率有关。     

SHR心肌细胞内钙离子浓度改变与左室肥厚和功能的关系

目的:探讨自发性高血压大鼠(SHR)心肌细胞内钙离子浓度的动态演变规律及其与左室肥厚和功能的相互关系。方法:应用Ca²⁺荧光指示剂Fura-2/AM分别测定了10周龄、22周龄、34周龄SHR心肌细胞内Ca²⁺浓度以及导管法测定了大鼠心功能,并以同龄京都-Wistar(WKY)大鼠作对照。结果:各周龄SHR收缩压(SBP)、心肌细胞内Ca²⁺浓度([Ca⁺]_i)、左室重量/体重(LVM/BW)均明显高于同龄正常血压WKY大鼠,22周龄SHR左室压力最大下降速率(-dp/dt_max)低于、左室松弛时间常数(τ)长于同龄WKY大鼠,34周龄SHR±dp／dt_max和左室收缩指数均显著低于同龄WKY大鼠,τ进一步延长;心肌细胞内[Ca⁺]_i与大鼠LVM/BW、SBP-dp／dt_max、τ呈显著正相关(r=0.47-0.83,P＜0.01),与dp／dt_max和收缩指数呈显著负相关(r=-0.46,P<0.05和-0.81,P<0.01)。结论:SHR心肌细胞内钙离子超负荷不仅介导了心肌肥厚的形成,还导致了心肌的收缩和舒张功能障碍。     

Calcium-dependent changes of paired-pulse modulation at single GABAergic synapses

Whole-cell patch-clamp and local electrical stimulation were used for measuring of monosynaptic GABAergic currents from rat hippocampal neurons in culture. Under control conditions (normal extracellular calcium, 2 mM) paired-pulse depression with 150 ms interpulse interval was observed. The mean current amplitude for both 1st and 2nd IPSCs displayed bell-shaped dependency from the stimulus amplitude. When extracellular Ca was either decreased to 0.5 mM or increased to 5 mM both mean amplitude of IPSCs and mean release probability decreased/increased correspondingly yet their dependences from the stimulus strength remained bell-shaped. Mean paired-pulse ratio was also affected--we observed facilitation of second IPSC in low-calcium whereas the latter was depressed in high-calcium solution. Our results suggest that calcium concentrations not only regulate the strength of paired-pulse plasticity but also can invert its direction.     

Effect of physical training on the development of hypertension in the spontaneously hypertensive rat

The effect of chronic physical exercise on the development of hypertension was measured in spontaneously hypertensive rats (SHR) and their progenitor normotensive wistar-kyoto controls (WK). Starting 4–5 weeks after birth groups of rats were subjected to swimming exercise 1 h×day^–1, 4 days×weeks^–1 for a total period of 11 weeks. Control rats were handled daily without exercise. Both in trained SHR and WK a significant delay in increase in body weight was observed. Physical training caused a small, but significant (P<0.001) reduction in systolic blood pressure of SHR, whereas it did not affect blood pressure in WK. Heart rate was significantly (P<0.001) lower in both trained SHR and WK than in their non-trained controls. At the end of the training period the degree of training was tested by measuring muscle cytochrome oxidase activity and relative heart weight. Cytochrome oxidase activity in gastrocnemius muscle was higher in the trained animals, although the difference was only significant (P<0.05) for WK. Training also caused a significant (P<0.01) increase in the ratio heart weight to body weight in WK. Both trained and non-trained SHR have a ca. 25% higher relative heart weight than WK controls. SHR hearts did not further hypertrophy as a consequence of physical exercise.These data indicate that swim training induces a trained state in both SHR and WK. Moreover, this form of training causes a slight, but significant attennation of the development of hypertension in SHR.     

Effect of age on intestinal calcium absorption and adaptation to dietary calcium.

To study the reported decline in intestinal calcium absorption with age, calcium active transport, immunoreactive calcium protein (CaBP) content, and alkaline phosphatase activity were measured in the intestine of two strains of rats aged 3-wk--20 mo. Calcium active transport, as measured by everted gut sacs from Sprague-Dawley rats, was greatest at 3 wk, but it declined rapidly with no active transport demonstrable at 3 mo or thereafter. CaBP content closely paralleled the decline in active transport, but alkaline phosphatase activity increased as active transport decreased. Intestinal adaptation to dietary calcium was studied by feeding high- and low-calcium diets to Fischer 344 rats aged 1.5--12 mo. In 1.5-mo-old rats fed a low-calcium diet, there was an increase in calcium active transport, CaBP content, and alkaline phosphatase activity relative to animals fed a high-calcium diet. However, the magnitude of this intestinal adaptation decreased with age until there was only marginal adaptation by 12 mo. The observed changes in calcium active transport with age and diet may be explained by the parallel changes in the vitamin D-dependent CaBP content of the intestine.     

Calcium appetite, blood pressure and electrolytes in spontaneously hypertensive rats

Appetite for solutions of 0.01 M-0.1 M calcium chloride or calcium lactate were assessed using the two-bottle choice technique in spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) normotensive rats fed calcium replete diets. SHR exhibited a marginally increased preference for calcium chloride and a significantly increased preference for calcium lactate (p less than 0.02). In SHR, but not in WKY, 28 days of calcium exposure via the preference test solutions significantly affected systolic blood pressure (p less than 0.03). The group of SHR ingesting calcium chloride had a lower mean systolic blood pressure, and that ingesting calcium lactate had a higher mean systolic blood pressure than the control group receiving no exposure to calcium in preference tests. Blood pressures of individual rats, however, were not related to cumulative milliequivalents of Ca consumed, body weight, whole blood or serum ionized Ca, K or Na concentrations, or total serum calcium. Strain differences in chemosensory sensitivity might play a role in mediating the enhanced self-selection of calcium by SHR.     

上调miR-133a表达水平对自发性高血压大鼠心肌纤维化的影响

目的:观察上调微小RNA-133a(miR-133a)的表达水平对自发性高血压大鼠(SHR)心肌纤维化的影响。方法:以同源正常血压Wistar-Kyoto(WKY)大鼠为正常对照组,另将SHR随机分为SHR组、SHR+腺相关病毒(AAV)组和SHR+携带miR-133a的腺相关病毒(miR-133a-AAV)组。通过冠脉灌注法将miR-133a-AAV转染至SHR大鼠的心脏,监测大鼠的尾动脉压,Masson染色观察心肌胶原沉积情况,real-time PCR检测心肌组织中miR-133a的表达水平,免疫组化法和Western blot法检测心肌组织中转化生长因子-β1(TGF-β1)和结缔组织生长因子(CTGF)的蛋白表达水平。结果:与WKY大鼠相比,SHR的尾动脉压明显升高,心肌组织中miR133a表达水平降低,TGF-β1和CTGF蛋白表达水平升高,出现心肌纤维化;上调SHR心肌miR-133a的表达水平后,心肌纤维化程度明显减轻,TGF-β1和CTGF蛋白表达水平降低。结论:上调心肌组织中miR-133a的表达水平,对高血压导致的大鼠心肌纤维化有改善作用,其机制可能与抑制心肌组织中TGF-β1和CTGF蛋白表达有关。     

Effects of calcium supplementation and deoxycorticosterone on plasma atrial natriuretic peptide and electrolyte excretion in spontaneously hypertensive rats.

The effects of calcium and the mineralocorticoid deoxycorticosterone (DOC) on blood pressure were studied in four groups of spontaneously hypertensive rats (SHR): (1) control; (2) calcium; (3) deoxycorticosterone and; (4) deoxycorticosterone + calcium. Calcium was given as 1.5% calcium chloride in drinking fluid and deoxycorticosterone by weekly subcutaneous injections (25 mg kg-1). During the nine weeks of treatment the increase in systolic blood pressure was enhanced in the deoxycorticosterone and attenuated in the calcium group, whereas the deoxycorticosterone + calcium group did not deviate from control. Total plasma calcium was elevated in the calcium group. Plasma concentrations of sodium and atrial natriuretic peptide (ANP) were increased by deoxycorticosterone while neither of the calcium-treated groups differed from control in these respects. Urinary excretions of calcium and sodium were increased in both groups receiving calcium, and also the deoxycorticosterone group excreted more calcium into urine than the control. Adrenergic nerve density in a section of the mesenteric artery and the urinary excretion of noradrenaline and adrenaline were similar in all study groups. The results indicate that calcium supplementation can attenuate the development of hypertension and prevent the deoxycorticosterone-induced blood pressure rise in SHR, possibly by influencing sodium metabolism as seen in increased natriuresis, and by preventing the actions of deoxycorticosterone on sodium balance.